Preclinical concept studies showing advantage of an inhaled anti-CTGF/CCN2 protein for pulmonary fibrosis treatment

Preclinical concept studies showing advantage of an inhaled anti-CTGF/CCN2 protein for pulmonary fibrosis treatment

Neiens, V., Hansbauer, EM., Jaquin, T.J. et al. (2025).

Nat Commun 16, 3251 (2025).


Read the publication